CleanPlex® SARS-CoV-2 Panel

CleanPlex® SARS-CoV-2 Panel

For Research Use Only. Not for use in diagnostic procedures.

  • CleanPlex® SARS-CoV-2 Panel for sequencing the whole genome of SARS-CoV-2 (the virus responsible for COVID-19) on Illumina Sequencing platform.

  • The panels are designed to obtain complete viral genomes even from samples with very low SARS-CoV-2 viral content.

Targeted Sequencing NGS Panels to Support SARS-CoV- 2 Research and Surveillance

Superb Performance

Prepare high-quality NGS libraries with excellent on-target performance using CleanPlex Technology to enable efficient use of sequencing reads. CleanPlex panels’ on-target rates are usually much higher than those of hybrid captured-based small target enrichment panels.

Fast, Streamlined Workflow

Generate sequencing-ready libraries in just 5.5 hours using a rapid, four-step protocol including RT step with minimal hands-on time.

High Coverage of Target Regions

Whole-genome coverage of the SARS-CoV-2 genome and selective coverage of influenza and RSV gene segments for sub-typing

Sensitive Detection

Can detect down to 1 copy with high confidence compared 3-5 copies by RT-qPCR (1)

Significant Cost Savings

99% reduction in sequencing cost. Only 30K–50K reads per sample required v.s. 10M reads required by many metagenomics sequencing methods.

Specifications

SKU

Description

Pack Size

SKU
Description
Pack Size

918010

CleanPlex® SARS-CoV-2 Panel

8 reactions

SKU
Description
Pack Size

918011

CleanPlex® SARS-CoV-2 Panel

96 reactions

SKU
Description
Pack Size

918010

CleanPlex® SARS-CoV-2 Panel

384 reactions

SKU
Description
Pack Size

716006

CleanPlex® Dual-Indexed PCR Primers for Illumina® Set A (12 x 8 indexes, 96 reactions)

96

SARS-CoV-2 Panel
arrow&v
arrow&v

Your content has been submitted

© 2021 Bioinnovations | Connecting Technologies to Life

Designed by Maveristic

Address

G1-G2, A-Wing, Hamirmal Tower, Station Rd, Bhayandar, Narayan Nagar, Bhayandar West, Mumbai, Maharashtra 401101, India

Quick Links